ArticleBMJ open2023

Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial.

Zhuoshan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.